/ EN
2026-06-12 00:00 United States Policy & Regulation Regulatory Approval Translated from EN

FDA Clears VoxNeuro Cognitive EEG Software

Summary The FDA cleared VoxNeuro's Cognitive Function Neuroimaging (cfNI) Software, version 1.0.0, on June 12, 2026, finding it substantially equivalent under submission number K253015 through the traditional 510(k) pathway. The agency classifies it as Normalizing Quantitative Electroencephalograph Software, a Class II device under regulation 882.1400, with neurology as the assigned review panel. Normalizing quantitative EEG software compares an individual's EEG metrics against a reference population database before reporting, supporting objective assessment of cognitive function.
Why it matters Normative-database qEEG puts the weight of the claim on the reference population rather than on the algorithm, so who is in that database, and whether the patient resembles them, becomes the practical limit on what a cognitive score means.

BCIwiki (bciwiki.com) — VoxNeuro, Inc. received an FDA 510(k) decision of Substantially Equivalent for Cognitive Function Neuroimaging (cfNI) Software (1.0.0) on June 12, 2026, under submission number K253015. The submission followed the Traditional 510(k) clearance pathway.

FDA lists the product under the device classification name Normalizing Quantitative Electroencephalograph Software. It is a Class 2 device under regulation number 882.1400, assigned to the Neurology advisory committee. Normalizing quantitative EEG software compares an individual's EEG metrics against a reference population database before reporting, supporting objective assessment of cognitive function.

Compiled by BCIwiki from public sources

Sources · 1
Read original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About